Fobi AI - CEO, Rob Anson.
CEO, Rob Anson.
Source: Fobi AI.
  • Fobi (FOBI) has signed a marketing deal with Abbot’s Butcher, a premium plant-based protein company
  • The company will outfit Abbot’s with its Qples digital coupon platform
  • It will earn revenue on a per-coupon basis
  • Fobi AI is a data intelligence company that turns real-time data into actionable insights and personalized customer engagement
  • Fobi Shares (FOBI) is down by 0.98 per cent trading at $1.01 per share

Fobi (FOBI) has signed a marketing deal with Abbot’s Butcher, a premium plant-based protein company.

The company will outfit Abbot’s with its Qples digital coupon platform.

It will generate revenue through an ongoing per-coupon revenue model.

Abbot’s has expanded into over 800 retail and foodservice locations across the U.S., including Whole Foods Market.  

“We are excited to partner with Qples by Fobi and to launch our first-ever digital coupons at Abbot’s Butcher. This will allow us to give back to our customers and drive trials for new customers,” stated Kristi Fanning, Abbot’s’ Marketing Director.

“This deal with Abbot’s Butcher continues our string of success with CPG brands, however, it is also very exciting as we are beginning to see success and expect exponential growth in our business in the health food industry,” added Rob Anson, Fobi’s CEO.

Fobi AI is a data intelligence company that turns real-time data into actionable insights and personalized customer engagement.

More From The Market Online

Independent tests of BlackBerry cyber defense scores solid results

A new study finds that BlackBerry’s (TSX:BB) endpoint protection platform blocked the most cyberattacks while using fewer system resources.

Buzz on the Bullboards: Looking for volatility-proof stocks?

Investors saw developments in Canadian and U.S. stock markets, with attention on decisions made by central banks and moves in key sectors.

TELUS becomes one of the first Canadian organizations to offer GenAI

TELUS (TSX:T) becomes one of the first Canadian organizations to offer GenAI solutions to its customer base.
Scientific labratory

How a small-cap tech stock is broadening MRI technology 

Nanalysis Scientific (TSXV:NSCI) develops and makes compact MRI and nuclear magnetic resonance devices for clinical, lab and industrial use.